Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

384

HTML

2987

Tables (1-4)

172

Sum=3543

Feb 28, 2010 (publication date) through Jul 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 28, 2010; 16(8): 982-986
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.982

Table 1 Patient characteristics (n = 286)

	n (%)
Age, yr (median ± IQR)	64 ± 30
Weight, kg (median ± IQR)	72 ± 23
Creatinine clearance, mL/min (median ± IQR)	71.5 ± 57.6
Age ≥ 65 yr	143 (51)
Male	149 (52)
Medical floor	146 (51)
Surgical floor	140 (49)
Dose 40 mg omeprazole	272 (95)
Frequency as once daily	251 (88)
Medications
Heparins	133 (47)
NSAIDs	74 (26)
Corticosteroids	74 (26)
Aspirin (100 mg)	42 (15)
Clopidogrel	15 (5)
Acenocoumarol	10 (4)

IQR: Interquartile range; NSAIDs: Non-steroidal-anti-inflammatory drugs.

Citation: Nasser SC, Nassif JG, Dimassi HI. Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients. World J Gastroenterol 2010; 16(8): 982-986
URL: https://www.wjgnet.com/1007-9327/full/v16/i8/982.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i8.982